Brisbane Times
·general
·1 hour ago
Everlab prioritizes safety over profit amid peptide demand and rapid growth
Everlab, a Melbourne health start-up, rejects requests for peptides, prioritizing safety over profit despite demand from about ten people daily. Chief Executive Marc Hermann noted a shift towards 20,000 members, including more older Australians. The start-up recently raised $65 million to support expansion into corporate services and the UK market.
Summary by Glance · Brisbane Times
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI